BIANCHINI M; SANCHEZ MB

In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy

Frontiers in Immunology; Año: 2023 vol. 14

BIANCHINI M

Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal

JOURNAL OF HEMATOLOGY AND ONCOLOGY; Año: 2023 vol. 16 p. 1 - 5

RUIZ, MARÍA SOL; SÁNCHEZ, MARÍA BELÉN; BONECKER, SIMONE; FURTADO, CAROLINA; KOILE, DANIEL; YANKILEVICH, PATRICIO; CRANCO, SANTIAGO; CUSTIDIANO, MARÍA DEL ROSARIO; FREITAS, JOSEFINA; MOIRAGHI, BEATRIZ; PÉREZ, MARIEL ANA; PAVLOVSKY, CAROLINA; VARELA, ANA INÉS; VENTRIGLIA, VERÓNICA; SÁNCHEZ ÁVALOS, JULIO CÉSAR; LARRIPA, IRENE; ZALCBERG, ILANA; MORDOH, JOSÉ; VALENT, PETER; BIANCHINI, MICHELE

miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool

Frontiers in Pharmacology; Año: 2021 vol. 11

BIANCHINI M

Shortcut characterization of BCR-ABL1 breakpoints on genomic DNA: main implications for assessment of the leukemic burden in chronic myeloid leukemia patients

CLINICAL CHEMISTRY AND LABORATORY MEDICINE; Lugar: Berlin; Año: 2021

BIANCHINI M

Treatment free remission in patients with chronic myeloid leukemia: recommendations of LALNET expert panel

Blood Advances; Lugar: Washington; Año: 2021

BIANCHINI, MICHELE

Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 Quantification in CML Patients: Findings and Recommendations

CLINICAL CHEMISTRY AND LABORATORY MEDICINE; Año: 2020 vol. 58 p. 2025 - 2035

BIANCHINI M

miRNome profiling of clonal stem cells in Ph+ CML

BioRxiv; Año: 2020

BIANCHINI M

Discontinuación del tratamiento en leucemia mieloide crónica. ¿Estamos preparados?

Hematologia; Lugar: Buenos Aires; Año: 2019 vol. 23

BIANCHINI M; RUIZ MS

Evaluation of the primitive fraction by functional in vitro assays at the RNA and DNA level represents a novel tool for complementing molecular monitoring in chronic myeloid leukemia

Oncotarget; Lugar: New York; Año: 2018 p. 20255 - 20264

RUIZ MS; SANCHEZ MB; MORDOH J; BIANCHINI M

Evaluation of the primitive fraction by functional in vitro assays at the RNA and DNA level represents a novel tool for complementing molecular monitoring in chronic myeloid leukemia

Oncotarget; Lugar: New York; Año: 2018 vol. 9 p. 20255 - 20264

ARRIAGA JM; BRAVO AI; MORDOH J; BIANCHINI M

Metallothionein 1G promotes differentiation of HT-29 human colorectal cancer cells

ONCOLOGY REPORTS; Lugar: Athens; Año: 2017 vol. 37 p. 2633 - 2651

BIANCHINI M; IRENE B. LARRIPA; RUIZ MS

Recomendaciones metodológicas para el monitoreo molecular de pacientes con Leucemia Mieloide Crónica por PCR cuantitativa en tiempo real del BCR-ABL1

MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2017

ARRIAGA JM; BRAVO AI; MORDOH J; BIANCHINI M

Metallothionein 1G promotes differentiation of HT-29 human colorectal cancer cells

ONCOLOGY REPORTS; Lugar: Athens; Año: 2016

RUIZ MS; IRENE B. LARRIPA; MORDOH J; TAPIA I; BIANCHINI M

Standardization of molecular monitoring for chronic myeloid leukemia in Latin America using locally produced secondary cellular calibrators.

LEUKEMIA; Lugar: Londres; Año: 2016 vol. 30 p. 2258 - 2260

FERRI C; BIANCHINI M; LARRIPA I

Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutation

EUROPEAN JOURNAL OF HAEMATOLOGY; Lugar: Londres; Año: 2015 vol. 94 p. 270 - 272

GONZALEZ MS; DE BRASI CD; FERRI CA; BENGIó RM; BIANCHINI M; LARRIPA I

CAMKIIã, HSP70 and HSP90 transcripts are differentially expressed in resistant mutated patients with Chronic Myeloid Leukemia

LEUKEMIA AND LYMPHOMA; Lugar: Londres; Año: 2014 vol. 55 p. 2101 - 2108

MARIANA SELENA GONZALEZ; CARLOS DANIEL DE BRASI; MICHELE BIANCHINI; PATRICIA GARGALLO; CARMEN STANGANELLI; IRENE BEATRIZ LARRIPA

Improved diagnosis of the transition to JAK2 V617F homozygosity: the key feature for predicting the evolution of myeloproliferative neoplasms

PLOS ONE; Lugar: San Francisco; Año: 2014 vol. 9 p. 1 - 8

FERRI C; BIANCHINI M; BENGIÓ R; LARRIPA I

Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy

BLOOD CELLS MOLECULES AND DISEASES; Lugar: Amsterdam; Año: 2014 vol. 52 p. 121 - 125

ARRIAGA JM; GRECO A; MORDOH J; BIANCHINI M

Metallothionein 1G and zinc sensitize human colorectal cancer cells to chemotherapy

MOLECULAR CANCER THERAPEUTICS; Lugar: Philadelphia; Año: 2014 vol. 13 p. 1369 - 1381

ROCCA, YAMILA; M.P. ROBERTI; ARRIAGA JM; AMAT M; L BRUNO; BIANCHINI M; MORDOH J; E.M. LEVY

ALTERED PHENOTYPE IN PERIPHERAL BLOOD AND TUMOR ASSOCIATED NATURAL KILLER CELLS FROM COLORECTAL CANCER PATIENTS

INNATE IMMUNITY; Lugar: London; Año: 2013 vol. 19 p. 76 - 85

FERRI C; BIANCHINI M; ICARDI G; LARRIPA I

Early detection and quantification of mutations in the tyrosine kinase domain of chimerical BCR-ABL1 gene combining high-resolution melting analysis and mutant-allele specific quantitative PCR

LEUKEMIA AND LYMPHOMA; Lugar: Londres; Año: 2013 vol. 54 p. 598 - 606

MP ROBERTI; MM BARRIO; AI BRAVO; YS ROCCA; JM ARRIAGA; M BIANCHINI; J MORDOH; EM LEVY

IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.

BREAST CANCER RESEARCH AND TREATMENT; Año: 2012 vol. 130 p. 465 - 475

JUAN M ARRIAGA; ESTRELLA M LEVY; ALICIA I BRAVO; BAYO MORALES S; MORA AMAT; ARIS MARIANA; A HANNOIS; L BRUNO; MARIA P ROBERTI; F SANCHEZ LORIA; A PAIROLA; E HUERTAS; J MORDOH; M BIANCHINI

Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival

HUMAN PATHOLOGY; Lugar: Philadelphia; Año: 2012 vol. 43 p. 197 - 208

M ARIS; M RODRIGUEZ ZUBIETA; M COLOMBO; JM ARRIAGA; M BIANCHINI; M ALPEROVICH; AI BRAVO; MM BARRIO; J MORDOH

MART-1- and gp100-Expressing and -Non-Expressing Melanoma Cells Are Equally Proliferative in Tumors and Clonogenic In Vitro

JOURNAL OF INVESTIGATIVE DERMATOLOGY; Lugar: Baltimore; Año: 2012 vol. 132 p. 365 - 374

ROBERTI, MARíA PAULA; ARRIAGA JUAN MARTIN; BIANCHINI MICHELE; BRAVO ALICIA INéS; LEVY ESTRELLA MARIEL; MORDOH JOSé; BARRIO MARíA MARCELA

Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice

CANCER BIOLOGY & THERAPY; Lugar: Austin, Texas; Año: 2012 vol. 13 p. 1123 - 1140

J.M. ARRIAGA; I.A. BRAVO; L. BRUNO; S. MORALES BAYO; A. HANNOIS; S. BAFFA TRASCI; E.M. LEVY; J. MORDOH; M. BIANCHINI

Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes’ stage B and C colorectal cancer

HUMAN PATHOLOGY; Año: 2012 vol. 43 p. 1695 - 1703

BELLI C.; ALÚ M.F.; ALFONSO G,; BIANCHINI M,; LARRIPA I.

Novel variant Ph translocation t(9;22;11)(q34;q11.2;p15)inv(9) (p13q34) at diagnosis as a good prognostic finding in chronic myeloid leukemia

CYTOGENETIC AND GENOME RESEARCH; Lugar: Basel; Año: 2011 vol. 132 p. 304 - 308

RAQUEL M. BENGIÓ; MARIA E. RIVA; BEATRIZ MOIRAGHI; ROSA SANTARELLI; FERNANDO BEZARES; EMILIO LANARI; JORGE MILONE; EDUARDO BULLORSKY; HECTOR MURRO; MICHELE BIANCHINI; IRENE LARRIPA

Clinical outcome of Chronic Myeloid Leukemia imatinib-resistant patients

LEUKEMIA AND LYMPHOMA; Lugar: London; Año: 2011 vol. 52 p. 1720 - 1726

S. RIVETTI; M. LAURIOLA; M. VOLTATTORNI; M. BIANCHINI; D. MARTINI; C. CECCARELLI; A. PALMIERI; G. MATTEI; M. FRANCHI; G. UGOLINI; G. ROSATI; I. MONTRONI; M. TAFFURELLI; R. SOLMI

Gene expression profile of human colon cancer cells treated with Cross Reacting Material 197, a diphteria toxin non toxic mutant

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY; Lugar: Chieti; Año: 2011 vol. 24 p. 639 - 649

MARIANA S. GONZALEZ; CARLOS D. DE BRASI; MICHELE BIANCHINI; PATRICIA GARGALLO; BEATRIZ MOIRAGUI; RAQUEL BENGIÓ; IRENE B. LARRIPA

BAX/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia

BLOOD CELLS MOLECULES AND DISEASES; Año: 2010 vol. 45 p. 192 - 196

BIANCHINI M; DE BRASI CARLOS; GARGALLO PATRICIA; GONZÁLEZ MARIANA; BENGIÓ RAQUEL; LARRIPA IRENE

Specific assessment of BCR-ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients

EUROPEAN JOURNAL OF HAEMATOLOGY; Lugar: Oxford; Año: 2009 vol. 82 p. 292 - 300

LEVY EM; SYCZ G; ARRIAGA JM; BARRIO MM; VON EUW EM; BAYO MORALES S; GONZALEZ M; MORDOH J; BIANCHINI M

Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells

INNATE IMMUNITY; Lugar: Los Angeles; Año: 2009 vol. 15 p. 91 - 100

CINZIA ZUCCHINI; ANNA ROCCHI; MARIA CRISTINA MANARA; PAOLA DE SANCTIS; CRISTINA CAPANNI; MICHELE BIANCHINI; PAOLO CARINCI; KATIA SCOTLANDI; LUISA VALVASSORI

Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines

INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Athens; Año: 2008 vol. 32 p. 17 - 31

VON EUW EM; BARRIO MM; FURMAN D; LEVY EM; BIANCHINI M; PEGUILLET I; LANTZ O; VELLICE A; KOHAN A; CHACÓN M; YEE C; WAINSTOK R; MORDOH J

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of diseas

JOURNAL OF TRANSLATIONAL MEDICINE; Lugar: England; Año: 2008 vol. 6 p. 1 - 14

LEVY EM; BIANCHINI M; VON EUW EM; BARRIO MM; BRAVO AI; FURMAN D; DOMENICHINI E; MACAGNO C; PINSKY V; ZUCCHINI C; VALVASSORI L; MORDOH J

Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer

INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Athens; Año: 2008 vol. 32 p. 633 - 641

VON EUW EM; BARRIO MM; FURMAN D; BIANCHINI M; LEVY EM; MORDOH J

Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8+ T lymphocytes

JOURNAL OF TRANSLATIONAL MEDICINE; Lugar: England; Año: 2007 p. 5 - 19

MARÝA SONIA BAQUEDANO; NORA SARACO; ESPERANZA BERENSZTEIN; CAROLINA PEPE; MICHELE BIANCHINI; ESTRELLA LEVY; JAVIER GON; MARCO A. RIVAROLA; ALICIA BELGOROSKY

Identification and Developmental Changes of Aromatase and Estrogen Receptor Expression in Prepubertal and Pubertal Human Adrenal Tissues

JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM; Lugar: United States; Año: 2007 vol. 92 p. 2215 - 2222

MICHELE BIANCHINI; GIOVANNI MARTINELLI; MATTEO RENZULLI; MARCELA GONZALEZ CID; IRENE LARRIPA

cDNA MICROARRAY STUDY TO IDENTIFY EXPRESSION CHANGES RELEVANT FOR APOPTOSIS IN K562 CELLS CO-TREATED WITH AMIFOSTINE AND IMATINIB

CANCER CHEMOTHERAPY AND PHARMACOLOGY; Lugar: Germany; Año: 2006 vol. 59 p. 349 - 360

BIANCHINI M; LEVY E; ZUCCHINI C; PINSKI V; MACAGNO C; DE SANCTIS P; VALVASSORI L; CARINCI P; MORDOH J

Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa

INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Greece; Año: 2006 vol. 29 p. 83 - 94

NGUYEN LN; HOLDREN MS; NGUYEN AP; FURUYA MH; BIANCHINI M; LEVY E; MORDOH J; LIU A; GUNCAY GD; CAMPBELL JS; PARKS T

Sorting Nexin 1Down-Regulation Promotes Colon Tumorigenesis

CLINICAL CANCER RESEARCH; Lugar: United States; Año: 2006 vol. 12 p. 6952 - 6959

PICCALUGA PP; LUATTI S; ASCANI S; BIANCHINI M; MALAGOLA M; RONDONI M; GAITANI S; TESTONI N; PILERI SA; BACCARANI M; MARTINELLI G; VISANI G

Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia.

CANCER GENETICS AND CYTOGENETICS; Lugar: United States; Año: 2004 vol. 151 p. 85 - 86

ZUCCHINI C; BIANCHINI M; VALVASSORI L; PERDICHIZZI S; BENINI S; MANARA MC; SOLMI R; STRIPPOLI P; PICCI P; CARINCI P; SCOTLANDI K

Identification of candidate genes for reversal of malignant phenotype in liver/bone/kidney alkaline phosphatase (L/B/K ALP) transfected osteosarcoma cell lines by means of cDNA microarray analysis

BONE; Lugar: United States; Año: 2004 vol. 34 p. 672 - 679

SOVERINI S; MARTINELLI G; AMABILE M; POERIO A; BIANCHINI M; ROSTI G; PANE F; SAGLIO G; BACCARANI M

Denaturing-HPLC-Based Assay for Detection of ABL Mutations in Chronic Myeloid Leukemia Patients Resistant to Imatinib

CLINICAL CHEMISTRY; Lugar: United States; Año: 2004 vol. 50 p. 1205 - 1213

PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BIANCHINI M; VIGNA E; BOSI C; GAITANI S; VISANI G; BACCARANI M

Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation

LEUKEMIA AND LYMPHOMA; Lugar: England; Año: 2004 vol. 45 p. 731 - 733

PICCALUGA PP; BIANCHINI M; MARTINELLI G

Novel FLT3 point mutation Ala680Val in acute myeloid leukaemia

LANCET ONCOLOGY; Lugar: England; Año: 2003 vol. 4 p. 604 - 604

BIANCHINI M; OTTAVIANI E; GRAFONE T; GIANNINI B; SOVERINI S; TERRAGNA C; AMABILE M; PICCALUGA PP; MALAGOLA M; RONDONI M; BOSI C; BACCARANI M; MARTINELLI G

Rapid detection of FLT3 mutations in acute myeloid leukemia patients by D-HPLC

CLINICAL CHEMISTRY; Lugar: United States; Año: 2003 vol. 49 p. 1642 - 1650

PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BIANCHINI M; VISANI G; BACCARANI M

Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature

HAEMATOLOGICA; Lugar: Italy; Año: 2003 vol. 88 p. 1 - 3

BIANCHINI M; RADRIZZANI M; BROCARDO MG; REYES GB; GONZALEZ SOLVEYRA C; SANTA-COLOMA TA

Specific oligobodies against ERK-2 that recognize both the native and the denatured state of the protein

JOURNAL OF IMMUNOLOGICAL METHODS; Lugar: Netherlands; Año: 2001 vol. 252 p. 191 - 197

BROCARDO MG; BIANCHINI M; RADRIZZANI M; REYES GB; DUGOUR AV; TAMINELLI GL; GONZALEZ SOLVEYRA C; SANTA-COLOMA TA

APC senses cell-cell contacts and moves to the nucleus upon their disruption

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS; Lugar: United States; Año: 2001 vol. 284 p. 982 - 986

RADRIZZANI M, BROCARDO MG, GONZALEZ SOLVEYRA C, BIANCHINI M, REYES GB, CAFFERATA EG, VILA ORTIZ G, SANTA-COLOMA TA.

Development of monoclonal oligobodies and chemically synthesized oligobodies

MEDICINA (BUENOS AIRES); Año: 2000 vol. 60 p. 55 - 60

RADRIZZANI M, BROCCARDO M, GONZALEZ SOLVEYRA C, BIANCHINI M, REYES GB, CAFFERATA EG, SANTA-COLOMA TA.

Oligobodies: bench made synthetic antibodies

MEDICINA (BUENOS AIRES); Año: 1999 vol. 59 p. 753 - 758